NIH-funded research R01 grant

Family psychoeducation for adults with psychotic disorders in Tanzania

Official title: Family Psychoeducation for Adults with Psychotic Disorders in Tanzania (KUPAA trial)

Funded at Univ of North Carolina Chapel Hill · NIH-11524688 · Data updated 2026-11-12

A culturally tailored, group-based program helps families support adults with psychotic disorders in Tanzania, aiming to improve daily functioning and quality of life.

More Psychotic Disorders research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJune 1, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$94,792
NIH project number3R01MH136145-03S3
Project IDNIH-11524688 on NIH RePORTER

Who could benefit from this research

Could help

Adults with psychotic disorders in Tanzania and their families who participate with caregiver involvement.

Less likely to help

Patients or families not engaging with the program or in settings where implementation challenges persist may see limited benefit.

What this research studies

This project tests a Swahili version of family psychoeducation called KUPAA, designed for adults with schizophrenia-spectrum disorders and their families in Tanzania. In a randomized design across 14 health facilities, patient-caregiver pairs receive either the KUPAA program or standard care, with outcomes focused on disability, quality of life, hospitalizations, and family burden. The study blends effectiveness and implementation aims to see not only if the program helps patients, but how it can be put into routine care in low-resource settings. Participants will be adults living with psychotic disorders and their family members, with care teams coordinating sessions.

Why it matters

Potential benefit: If successful, patients could experience fewer disabilities and better quality of life, along with reduced caregiver burden.

How similar studies have gone: Prior pilot testing in Tanzania suggested feasibility and potential benefit, and this trial seeks to confirm effectiveness at scale.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Baumgartner, Joy Noel — Univ of North Carolina Chapel Hill
  • Study coordinator: Baumgartner, Joy Noel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.